Stephan Moser

Bausch, Severin, Dräger, Sarah, Charitos-Fragkakis, Panteleimon, Egli, Adrian, Moser, Stephan, Hinic, Vladimira, Kuehl, Richard, Bassetti, Stefano, Siegemund, Martin, Rentsch, Katharina M., Hermann, Laura, Schöning, Verena, Hammann, Felix, Sendi, Parham, & Osthoff, Michael. (2024). Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive Staphylococcus aureus Infections: A Prospective Cohort Study [Journal-article]. Antibiotics, 13(10), 928. https://doi.org/10.3390/antibiotics13100928

Moser, Stephan, Araschmid, Laura, Panagiotou, Anneza, Bonati, Leo H., Breidthardt, Tobias, Fahrni, Gregor, Kaiser, Christoph, Jeger, Raban, Trendelenburg, Marten, & Osthoff, Michael. (2024). Association of Endothelial Cell Activation with Acute Kidney Injury during Coronary Angiography and the Influence of Recombinant Human C1 Inhibitor—A Secondary Analysis of a Randomized, Placebo-Controlled, Double-Blind Trial [Journal-article]. Biomedicines, 12(9), 1956. https://doi.org/10.3390/biomedicines12091956

Urwyler, Pascal, Leimbacher, Marina, Charitos, Panteleimon, Moser, Stephan, Heijnen, Ingmar A. F. M., Trendelenburg, Marten, Thoma, Reto, Sumer, Johannes, Camacho-Ortiz, Adrián, Bacci, Marcelo R., Huber, Lars C., Stüssi-Helbling, Melina, Albrich, Werner C., Sendi, Parham, & Osthoff, Michael. (2023). Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1255292

Bruni F, Charitos P, Lampart M, Moser S, Siegemund M, Bingisser R, Osswald S, Bassetti S, Twerenbold R, Trendelenburg M, Rentsch KM, & Osthoff M. (2022). Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study. Frontiers in Immunology, 13, 941742. https://doi.org/10.3389/fimmu.2022.941742

Urwyler, Pascal, Moser, Stephan, Trendelenburg, Marten, Sendi, Parham, & Osthoff, Michael. (2022). Targeting thromboinflammation in COVID-19 – A narrative review of the potential of C1 inhibitor to prevent disease progression. Molecular Immunology, 150, 99–113. https://doi.org/10.1016/j.molimm.2022.08.008

Moser S., Rehm S., Guertler N., Hinic V., Drager S., Bassetti S., Rentsch K.M., Sendi P., & Osthoff M. (2021). Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: A prospective cohort study of unbound plasma and individual MICs. Journal of Antimicrobial Chemotherapy, 76(7), 1845–1854. https://doi.org/10.1093/jac/dkab089

Urwyler, Pascal, Charitos, Panteleimon, Moser, Stephan, Heijnen, Ingmar A. F. M., Trendelenburg, Marten, Thoma, Reto, Sumer, Johannes, Camacho-Ortiz, Adrián, Bacci, Marcelo R., Huber, Lars C., Stüssi-Helbling, Melina, Albrich, Werner C., Sendi, Parham, & Osthoff, Michael. (2021). Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19). Trials, 22(1). https://doi.org/10.1186/s13063-020-04976-x

Gürtler N, Linnemann D, Moser S, Dräger S, & Osthoff M. (2020). [Hematochezia and right-sided upper abdominal pain after puncture of a liver abscess in a 75-year-old male]. Der Internist, 61(5), 513–517. https://doi.org/10.1007/s00108-020-00781-5

Panagiotou A, Trendelenburg M, Heijnen IAFM, Moser S, Bonati LH, Breidthardt T, Fahrni G, Kaiser C, Jeger R, & Osthoff M. (2020). A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury. JACC. Cardiovascular Interventions, 13(7), 833–842. https://doi.org/10.1016/j.jcin.2019.11.021

Urwyler, Pascal, Moser, Stephan, Charitos, Panteleimon, Heijnen, Ingmar A. F. M., Rudin, Melanie, Sommer, Gregor, Giannetti, Bruno M., Bassetti, Stefano, Sendi, Parham, Trendelenburg, Marten, & Osthoff, Michael. (2020). Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.02072

Troeger, C., Perahud, I., Moser, S., & Holzgreve, W. (2010). Transplacental traffic after in utero mesenchymal stem cell transplantation. Stem Cells and Development, 19(9), 1385–1392. https://doi.org/10.1089/scd.2009.0434